Awareness, attitudes, and clinical utilization of vonoprazan for Helicobacter pylori infection and gastroesophageal reflux disease among Chinese physicians: a nationwide cross-sectional study
In this national sample, Chinese physicians demonstrated moderate awareness but limited real-world use of vonoprazan for H. pylori infection and GERD. Utilization was largely confined to tertiary centers and gastroenterology specialists. Broader educational initiatives, inclusion in hospital formularies, reimbursement alignment, and generation of real-world evidence may help facilitate appropriate and equitable adoption of vonoprazan in clinical practice.
Authors
- Hui Xu (ORCID: https://orcid.org/0000-0001-5517-3556)
- Heqing Tao (ORCID: https://orcid.org/0000-0002-8336-7312)
- Ligang Liu (ORCID: https://orcid.org/0000-0003-4352-1431)
- Hao Zhao (ORCID: https://orcid.org/0000-0002-1541-8579)
Institutions
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Beijing Chang'an Integrated Traditional Chinese and Western Medicine Hospital (CN)
- Beijing YouAn Hospital (CN)
- Beijing Hospital of Traditional Chinese Medicine (CN)
- Beijing Shijitan Hospital (CN)
- Guangzhou Medical University (CN)
- Western University of Health Sciences (US)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1186/s12876-025-04408-7
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00